EDGE MEDICAL-B: On October 30, 2026, EDGE MEDICAL-B (02675) repurchased 119,200 H shares on the SEHK open market under its repurchase mandate at an average of HKD 31.2704 per share, involving about HKD 3.73 million; as a consequence, Jianchen Wang is deemed to be interested in these treasury shares under the SFO, and although the transaction was matched on the SEHK open market, it was not a direct secondary-market dealing by Wang.
Prior to the acquisition, Jianchen Wang’s long position in EDGE MEDICAL-B was 124.39 million shares, representing 37.95%; following the acquisition, the holding changed to 124.51 million shares, with the long position ratio rising to 37.99%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments